ASX-listed anti-ageing and hair loss treatment business Anagenics said its chief executive Maria Halasz resigned on Monday in an announcement that failed to declare either thanks or praise for her 15 years in the role. Shares in the business are down around 90 per cent since the start of 2018.The Australian Financial Review
Under the April 29, 2021, deal agreed by Ms Halasz and the Cellmid board all of Lyramid’s issued capital was sold to Provelmare for $0.5 million plus retained rights to 4 per cent of royalties on any product sales, and 8 per cent of any sub-licence fees. Cellmid was also entitled to a 4 per cent sell-on fee of Lyramid, and retained ownership of its midkine patents.
The deal took Roquefort’s issued capital to 71.9 million shares including 36.9 million already on issue, the 5 million issued to Provelmare, and 30 million to new investors. It has not been disclosed how much cash on hand Roquefort had before the Lyramid capital raising and acquisition, although its nominal capital value was listed as £0.37 million as at August 18, 2021.
On April 1, 2021, less than a month before the deal was struck to sell Lyramid to Provelmare, Mr Whiddon held 500,000 share options in Cellmid via his Getmeoutofhere Pty Ltd. Mr Whiddon’s Roquefort stake was worth around £0.7 million on February 22 based on a 9.53 pence share price, with Provelmare’s stake worth around £0.48 million. Roquefort shares closed down 5.2 per cent to 9.25 pence on Monday in the UK.Mr Whiddon is described as an experienced company executive who also holds a director role at ASX-listed Calima Energy.
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
แหล่ง: theage - 🏆 8. / 77 อ่านเพิ่มเติม »